These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 19346023

  • 1. The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland.
    Timonen J, Karttunen P, Bengtström M, Ahonen R.
    Health Policy; 2009 Oct; 92(2-3):116-23. PubMed ID: 19346023
    [Abstract] [Full Text] [Related]

  • 2. The impact of generic substitution on price competition in Finland.
    Aalto-Setälä V.
    Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226
    [Abstract] [Full Text] [Related]

  • 3. The impact of generic substitution on the activities of pharmaceutical companies - a survey from the companies' perspective one year and five years after the introduction of generic substitution in finland.
    Timonen J, Bengtström M, Karttunen P, Ahonen R.
    BMC Clin Pharmacol; 2010 Oct 22; 10():15. PubMed ID: 20964869
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Folly or volley? Will a dollar $4 pill finally open the healthcare market to competitive pricing?
    Sturm AC.
    Healthc Financ Manage; 2006 Nov 22; 60(11):120-2. PubMed ID: 17094287
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of generic competition on the price of brand-name drugs.
    Lexchin J.
    Health Policy; 2004 Apr 22; 68(1):47-54. PubMed ID: 15033552
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The Eleventh Circuit holds that agreements in which pharmaceutical companies pay generic companies not to compete may be valid.
    Garrigues A.
    J Law Med Ethics; 2004 Apr 22; 32(1):181-4. PubMed ID: 15152443
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Are we living in the end of the blockbuster drug era?
    Debnath B, Al-Mawsawi LQ, Neamati N.
    Drug News Perspect; 2010 Dec 22; 23(10):670-84. PubMed ID: 21180653
    [Abstract] [Full Text] [Related]

  • 17. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M, Zavras D, Hatzikou M, Kyriopoulos J.
    Health Policy; 2006 Nov 22; 79(1):35-48. PubMed ID: 16386326
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Congress works to permit 'biosimilar' drugs very soon.
    Carroll J.
    Manag Care; 2009 Apr 22; 18(4):7-8. PubMed ID: 19472559
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.